Biotinylated Anti-Bevacizumab Antibody (AY13) (recommended for PK/PD)
A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF). Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.
Product #: BEB-BY13-200ug-202 Unit size: 200ug*1 Supplier: ACROBiosystems Available in the following countries:
Got any questions?
Get in touch with one of our specialists
Cristina Battagli
Product Specialist: Diagnostics, Metabolomics, Imaging & Cell Biology
